← Journal search
JOURNAL PROFILE
Download details (PDF) ↓

Amyloid (ISSN 1350-6129, 1744-2818) is a journal published by Taylor & Francis in the United Kingdom. It covers Medicine, Internal Medicine and Medicine (miscellaneous). It is indexed in Scopus, Web of Science, MEDLINE, PubMed and HEC. Recorded metrics: impact factor 5.1, Scopus Q1, Web of Science Q2, CiteScore 12.5 and HEC W-Category. Article processing charge: USD 2,950. This profile brings together the journal's ISSN, publisher, country, subject area, HEC category, Scopus data, SJR and SCImago rank, Web of Science data, impact factor, indexing, open access status, APC, aims and scope, about the journal, author instructions, journal website and registration details from the most reputable indexes, in one place.

Journal title

Amyloid

ISSN
1350-6129, 1744-2818
Subject area
MedicineInternal MedicineMedicine (miscellaneous)
Indexed
ScopusWeb of ScienceMEDLINEPubMedHEC
Scopus Quartile
Q1
WoS Quartile
Q2
Impact Factor
5.1
Country
United Kingdom
Publisher
Taylor & Francis
SJR
2.194
Open access
No
APC (USD)
2950
About the journal
Amyloid is the official journal of the International Society of Amyloidosis. Amyloid publishes basic and clinical research on amyloids and systemic and localized amyloidosis. The journal's scope and major areas of focus are: Etiology Epidemiology Genetics Pathogenesis, including chemical structure, fibrillogenesis and mechanism of disease Pathology Diagnosis, treatment and prognosis across a broad spectrum of clinical specialties impacted by various amyloid diseases and related disorders. The journal publishes research articles, letters to the Editor, review articles and article commentaries (typically by invitation). Authors can choose to publish gold open access in this journal.
Aims and Scope
Amyloid is the official journal of the International Society of Amyloidosis. Amyloid publishes basic and clinical research on amyloids and systemic and localized amyloidosis. The journal's scope and major areas of focus are: Etiology Epidemiology Genetics Pathogenesis, including chemical structure, fibrillogenesis and mechanism of disease Pathology Diagnosis, treatment and prognosis across a broad spectrum of clinical specialties impacted by various amyloid diseases and related disorders. The journal publishes research articles, letters to the Editor, review articles and article commentaries (typically by invitation). Authors can choose to publish gold open access in this journal.
Journal Website
Journal Website Direct Link ↗
Instructions for Authors URL
Journal's Author Direct Link ↗
Scopus URL
Scopus Direct Link ↗
APC Information URL
APC Information Direct Link ↗
WoS URL
Web of Science Direct Link ↗
SCImago Ranking
1200
HEC
W-Category
Registered In
1994
Average Time To Publication After Submission (In Weeks)
—
Waiver policy
—
Scopus Cite Score
12.5
WoS Status
Science Citation Index Expanded (SCIE)

Record last updated . Check current status at HEC HJRS, Scopus and the Web of Science Master Journal List before submitting. About our data.

Quick answers about Amyloid

Is Amyloid HEC recognised?

Yes. The catalogue records Amyloid in HEC category W of the HEC Journal Recognition System, where W is the highest and Y the lowest category. Confirm the current category on HEC's HJRS website before you submit.

Is Amyloid indexed in Scopus?

Yes. Amyloid is listed as Scopus-indexed, in quartile Q1, with a CiteScore of 12.5. Check its current status on the Scopus Sources page.

Is Amyloid in Web of Science?

Yes. Amyloid is listed as a Web of Science journal in the Science Citation Index Expanded (SCIE), with Web of Science quartile Q2. Confirm on Clarivate's Master Journal List.

What is the impact factor of Amyloid?

The recorded journal impact factor of Amyloid is 5.1. Clarivate updates impact factors every year in Journal Citation Reports.

Is Amyloid open access, and what does it charge?

Amyloid is not recorded as fully open access and its APC is USD 2,950. Fees change, so check the journal's website before you submit.

Who publishes Amyloid?

Amyloid is published by Taylor & Francis in United Kingdom, under ISSN 1350-6129 and 1744-2818.

Research profile

Main research topics: Amyloidosis: Diagnosis, Treatment, Outcomes, Alzheimer's disease research and treatments, Prion Diseases and Protein Misfolding, Multiple Myeloma Research and Treatments, Cardiac tumors and thrombi, Hereditary Neurological Disorders.

Source: OpenAlex (CC0), retrieved 20 November 2026. Counts cover works OpenAlex has indexed and differ from Scopus and Web of Science.

Browse similar journals

Find Journal